BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28068933)

  • 1. Screening for onconeural antibodies in neuromyelitis optica spectrum disorders.
    Berger B; Hottenrott T; Rauer S; Stich O
    BMC Neurol; 2017 Jan; 17(1):5. PubMed ID: 28068933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies.
    Sepúlveda M; Sola-Valls N; Escudero D; Rojc B; Barón M; Hernández-Echebarría L; Gómez B; Dalmau J; Saiz A; Graus F
    Mult Scler; 2018 Nov; 24(13):1753-1759. PubMed ID: 28920766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies.
    Mejdoub S; Feki S; Dammak M; Farhat N; Hdiji O; Boukthir S; Hachicha H; Mhiri C; Masmoudi H
    Rev Neurol (Paris); 2020 May; 176(4):261-267. PubMed ID: 31668529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
    Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation.
    Beauchemin P; Iorio R; Traboulsee AL; Field T; Tinker AV; Carruthers RL
    Mult Scler Relat Disord; 2018 Feb; 20():37-42. PubMed ID: 29291482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis Optica Spectrum Disorders.
    Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
    Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiculopathy in neuromyelitis optica. How does anti-AQP4 Ab involve PNS?
    Kim S; Park J; Kwon BS; Park JW; Lee HJ; Choi JH; Nam K
    Mult Scler Relat Disord; 2017 Nov; 18():77-81. PubMed ID: 29141825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
    Tuller F; Holzer H; Schanda K; Aboulenein-Djamshidian F; Höftberger R; Khalil M; Seifert-Held T; Leutmezer F; Berger T; Reindl M
    J Neuroinflammation; 2016 Jul; 13(1):176. PubMed ID: 27371173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
    Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
    Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
    Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
    Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.
    Sato DK; Callegaro D; Lana-Peixoto MA; Nakashima I; Fujihara K
    Arq Neuropsiquiatr; 2014 Jun; 72(6):445-50. PubMed ID: 24964112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study.
    Kessler RA; Mealy MA; Jimenez-Arango JA; Quan C; Paul F; López R; Hopkins S; Levy M
    Mult Scler Relat Disord; 2017 Oct; 17():198-201. PubMed ID: 29055457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature.
    Cai G; He D; Chu L; Dai Q; Xu Z; Zhang Y
    Int J Neurosci; 2016; 126(7):660-8. PubMed ID: 26010208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of aquaporin 4 antibody in the injury of retinal microstructure in neuromyelitis optica spectrum disorders].
    Wang ZW; Wang QQ; Diao DW; Guo QF; Qi XK
    Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):435-439. PubMed ID: 29925129
    [No Abstract]   [Full Text] [Related]  

  • 17. Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseases.
    Katsumata Y; Kawachi I; Kawaguchi Y; Gono T; Ichida H; Hara M; Yamanaka H
    Mod Rheumatol; 2012 Sep; 22(5):676-84. PubMed ID: 22183613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis optica spectrum disorder associated with dengue virus infection.
    Lana-Peixoto MA; Pedrosa D; Talim N; Amaral JMSS; Horta A; Kleinpaul R
    J Neuroimmunol; 2018 May; 318():53-55. PubMed ID: 29475624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
    Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
    J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
    Jarius S; Jacobi C; de Seze J; Zephir H; Paul F; Franciotta D; Rommer P; Mader S; Kleiter I; Reindl M; Akman-Demir G; Seifert-Held T; Kristoferitsch W; Melms A; Wandinger KP; Wildemann B
    Mult Scler; 2011 Sep; 17(9):1067-73. PubMed ID: 21543553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.